Tolfenamic acid inhibits leukotriene B4-induced chemotaxis of polymorphonuclear leukocytes in vitro
- 1 April 1991
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 15 (2) , 137-143
- https://doi.org/10.1007/bf00917508
Abstract
Inhibition of prostanoid synthesis is usually regarded as the mode of action of nonsteroidal antiinflammatory drugs (NSAIDs). In addition, some NSAIDs have been reported to have prostanoid-independent inhibitory effects on neutrophil functions. In the present study, we examined the effects of acetylsalicylic acid, diclofenac, indomethacin, ketoprofen, piroxicam and tolfenamic acid on leukotriene B4 (LTB4)-induced chemotaxis of human polymorphonuclear leukocytes (PMNs) in vitro. Tolfenamic acid inhibited LTB4-induced chemotaxis (IC50 59μM), whereas the other compounds were ineffective. Tolfenamic acid inhibited also FMLP-induced chemotaxis at the same concentration range (IC50 46μM). About 25% reduction in the chemotactic response was achieved with therapeutic concentrations of tolfenamic acid. We suggest that the inhibition of PMN chemotaxis is an additional mechanism in the antiinflammatory action of tolfenamic acid and that this action is not ligand specific.Keywords
This publication has 25 references indexed in Scilit:
- Orally administered tolfenamic acid inhibits leukotriene synthesis in isolated human peripheral polymorphonuclear leukocytesInflammation Research, 1989
- The mechanisms of action of nonsteroidal antiinflammatory drugsArthritis & Rheumatism, 1989
- Effects of antirheumatic drugs on leukotriene B4 and prostanoid synthesis in human polymorphonuclear leukocytesin vitroInflammation Research, 1988
- Meclofenamate sodium monohydrate inhibits chemotactic factor–induced human polymorphonuclear leukocyte function. a possible explanation for its antiinflammatory effectArthritis & Rheumatism, 1987
- Local Effects of Synthetic Leukotrienes (LTC4, LTD4, and LTB4) in Human SkinJournal of Investigative Dermatology, 1983
- CHEMOTACTIC LEUKOTRIENES IN PSORIASISThe Lancet, 1982
- LEUKOTRIENE B4, AN INFLAMMATORY MEDIATOR IN GOUTThe Lancet, 1982
- PSORIASIS AND LEUKOTRIENE B4The Lancet, 1982
- Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis.Journal of Clinical Investigation, 1980
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980